Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 25Urinary Bladder Neoplasms 5Carcinoma, Renal Cell 5Testicular Neoplasms 2Neoplasms 2Kidney Neoplasms 2Tooth, Impacted 1Thromboembolism 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Prostate Adenocarcinoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Muscle-invasive Bladder Cancer 1Lung Neoplasms 1Infertility, Male 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1Adenocarcinoma of the Prostate 1

Interventions

enzalutamide 2sipuleucel-T 1pazopanib 1capivasertib 1Watchful Waiting 1STA 9090 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiosurgery 1Dutasteride 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of the Prostate × Watchful Waiting × Genitourinary × Clear all
NCT01795365 2018-09-28

Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer

Centre Hospitalier Universitaire Vaudois

Phase NA Terminated
60 enrolled
Genitourinary

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡